Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Zevalin radioimmunotherapy receives European approval

Jan. 26, 2004

CytoGenix and Baylor to test aerosol gene silencing agent on mouse lung cancer

Jan. 23, 2004

OSI commences rolling NDA submission for Tarceva for NSCLC

Jan. 23, 2004

PI-88 enters phase II melanoma trial

Jan. 23, 2004

Tubercin shows activity in mouse metastatic melanoma

Jan. 23, 2004

Mercian and Eisai present novel VEGF production inhibitors for cancer therapy

Jan. 23, 2004

Indian scientists identify antitumor agents with antimitotic, anti-VEGF and proapoptotic activity

Jan. 23, 2004

Pfizer describes prinomastat metabolites and their use as MMP inhibitors

Jan. 23, 2004

Wilex claims new urokinase inhibitors and their use as antitumor agents

Jan. 23, 2004

Triapine enters NCI-sponsored clinical trials

Jan. 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...